• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人体血浆血管加压素对强效袢利尿剂的反应。

Human plasma vasopressin response to potent loop-diuretic drugs.

作者信息

Baylis P H, De Beer F C

出版信息

Eur J Clin Pharmacol. 1981;20(5):343-6. doi: 10.1007/BF00615403.

DOI:10.1007/BF00615403
PMID:7286044
Abstract

To investigate the effect of potent loop diuretic drugs on the factors that control water excretion, immunoreactive plasma arginine vasopressin was measured at regular intervals for 6 h after intravenous administration of frusemide (40 mg) and piretanide (12 mg) in healthy adults. Despite a large diuresis there was no significant rise in plasma vasopressin compared to controls. Diuretic drug treatment caused small increases in plasma osmolality comparable to the control group, but no change in mean arterial blood pressure. The fall in blood volume of 7% within 1 h of frusemide administration was insufficient to stimulate vasopressin secretion. We conclude that loop diuretic drugs in the dose given have little effect on plasma vasopressin and osmolality but cause a small fall in blood volume in healthy adults.

摘要

为研究强效袢利尿剂对控制水排泄的因素的影响,在健康成年人静脉注射速尿(40毫克)和吡咯他尼(12毫克)后,每隔一定时间测量6小时的免疫反应性血浆精氨酸加压素。尽管出现大量利尿,但与对照组相比,血浆加压素没有显著升高。利尿剂治疗使血浆渗透压略有升高,与对照组相当,但平均动脉血压没有变化。速尿给药后1小时内血容量下降7%,不足以刺激加压素分泌。我们得出结论,所给剂量的袢利尿剂对血浆加压素和渗透压影响很小,但会使健康成年人的血容量略有下降。

相似文献

1
Human plasma vasopressin response to potent loop-diuretic drugs.人体血浆血管加压素对强效袢利尿剂的反应。
Eur J Clin Pharmacol. 1981;20(5):343-6. doi: 10.1007/BF00615403.
2
Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men.强效利水性药物。一种新型非肽类选择性血管加压素2拮抗剂(OPC - 31260)在男性中的应用。
J Clin Invest. 1993 Dec;92(6):2653-9. doi: 10.1172/JCI116881.
3
Protective effect of loop diuretics, piretanide and frusemide, against sodium metabisulphite-induced bronchoconstriction in asthma.袢利尿剂(吡咯他尼和呋塞米)对亚硫酸氢钠诱发的哮喘患者支气管收缩的保护作用。
Eur Respir J. 1992 Nov;5(10):1184-8.
4
The effects of the loop diuretics furosemide and torasemide on diuresis in dogs and cats.袢利尿剂呋塞米和托拉塞米对犬猫利尿作用的影响。
J Vet Med Sci. 2003 Oct;65(10):1057-61. doi: 10.1292/jvms.65.1057.
5
Piretanide (HOE 118): a new potent diuretic: preliminary communication.吡咯他尼(HOE 118):一种新型强效利尿剂:初步通讯
N Z Med J. 1979 Feb 14;89(629):87.
6
The effects of piretanide on catecholamine metabolism, plasma renin activity and plasma aldosterone: a double-blind study versus furosemide in healthy volunteers.吡咯他尼对儿茶酚胺代谢、血浆肾素活性和血浆醛固酮的影响:一项在健康志愿者中与呋塞米对比的双盲研究。
Curr Med Res Opin. 1985;9(7):461-74. doi: 10.1185/03007998509109620.
7
Effects of a new diuretic (piretanide) compared with furosemide on renal diluting and concentrating mechanisms in patients with the nephrotic syndrome.一种新型利尿剂(吡咯他尼)与呋塞米相比对肾病综合征患者肾脏稀释和浓缩机制的影响。
Eur J Clin Pharmacol. 1980;17(3):165-71. doi: 10.1007/BF00561895.
8
Comparison of hemodynamic effects of furosemide and piretanide in normovolemic patients.速尿和布美他尼对血容量正常患者血流动力学影响的比较。
J Cardiovasc Pharmacol. 1980;2(2):103-11. doi: 10.1097/00005344-198003000-00002.
9
Influence of cardiac function on the diuretic and hemodynamic effects of the loop diuretic piretanide.心功能对襻利尿剂吡咯他尼的利尿及血流动力学效应的影响
Clin Cardiol. 1987 Feb;10(2):83-8. doi: 10.1002/clc.4960100203.
10
Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure.托伐普坦对充血性心力衰竭犬全身及肾脏血液动力学功能的影响。
Cardiovasc Drugs Ther. 2011 Dec;25 Suppl 1:S67-76. doi: 10.1007/s10557-011-6350-4.

引用本文的文献

1
Relative Blood Volume Profiles Hours After Loop Diuretic Administration: A Systematic Review and Meta-analysis.袢利尿剂给药后数小时的相对血容量变化曲线:一项系统评价和荟萃分析
CJC Open. 2023 May 18;5(8):641-649. doi: 10.1016/j.cjco.2023.05.003. eCollection 2023 Aug.
2
SGLT2 inhibitor and loop diuretic induce different vasopressin and fluid homeostatic responses in nondiabetic rats.SGLT2 抑制剂和袢利尿剂在非糖尿病大鼠中引起不同的血管加压素和液体稳态反应。
Am J Physiol Renal Physiol. 2022 Sep 1;323(3):F361-F369. doi: 10.1152/ajprenal.00070.2022. Epub 2022 Jul 28.
3
Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes.

本文引用的文献

1
The antidiuretic hormone and the factors which determine its release.抗利尿激素及其释放的决定因素。
Proc R Soc Lond B Biol Sci. 1947 Dec 16;135(878):25-106.
2
Plasma vasopressin response to hypertonic saline infusion to assess posterior pituitary function.通过静脉输注高渗盐水评估垂体后叶功能时的血浆血管加压素反应。
J R Soc Med. 1980 Apr;73(4):255-60. doi: 10.1177/014107688007300408.
3
Effect of moderate hemorrhage in humans on plasma ADH and renin.人体中度出血对血浆抗利尿激素和肾素的影响。
精氨酸加压素介导的代偿性胰高血糖素释放,并在 1 型糖尿病中减少。
Elife. 2021 Nov 17;10:e72919. doi: 10.7554/eLife.72919.
4
Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.吡咯他尼。对其药效学、药代动力学特性及治疗效果的初步综述。
Drugs. 1985 Jun;29(6):489-530. doi: 10.2165/00003495-198529060-00002.
5
Intravenous bumetanide attenuates the rise in plasma vasopressin concentrations during major surgical operations.静脉注射布美他尼可减轻大手术期间血浆血管加压素浓度的升高。
Br J Clin Pharmacol. 1987 Feb;23(2):237-40. doi: 10.1111/j.1365-2125.1987.tb03036.x.
Proc Soc Exp Biol Med. 1974 Jan;145(1):277-80. doi: 10.3181/00379727-145-37792.
4
Effect of angiotensin and of frusemide on plasma aldosterone, corticosterone, cortisol and renin in man.血管紧张素和速尿对人体血浆醛固酮、皮质酮、皮质醇和肾素的影响。
Lancet. 1965 Nov 13;2(7420):989-91. doi: 10.1016/s0140-6736(65)92847-3.
5
Stimulated renin: a screening test for hypertension.刺激肾素:一种高血压筛查试验。
Ann Intern Med. 1975 Jan;82(1):27-34. doi: 10.7326/0003-4819-82-1-27.
6
The early effects of intravenous frusemide on central haemodynamics, venous tone and plasma renin activity.静脉注射速尿对中心血流动力学、静脉张力和血浆肾素活性的早期影响。
Clin Sci Mol Med. 1975 Dec;49(6):551-5. doi: 10.1042/cs0490551.
7
The development of a radioimmunoassay for the measurement of human plasma arginine vasopressin.一种用于测量人血浆精氨酸加压素的放射免疫测定法的开发。
Clin Endocrinol (Oxf). 1977 Aug;7(2):91-102. doi: 10.1111/j.1365-2265.1977.tb01300.x.
8
Influence of presyncope and postural change upon plasma arginine vasopressing concentration in hydrated and dehydrated man.前驱晕厥和体位变化对水合及脱水状态下人体血浆精氨酸加压素浓度的影响。
Clin Endocrinol (Oxf). 1977 Jul;7(1):79-83. doi: 10.1111/j.1365-2265.1977.tb02942.x.
9
Determinants of response to frusemide in normal subjects.正常受试者对速尿反应的决定因素。
Br J Clin Pharmacol. 1977 Apr;4(2):121-7. doi: 10.1111/j.1365-2125.1977.tb00682.x.
10
The regulation of vasopressin function in health and disease.血管加压素在健康与疾病中的功能调节
Recent Prog Horm Res. 1976;33:333-85. doi: 10.1016/b978-0-12-571133-3.50015-5.